Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B.

Source:http://linkedlifedata.com/resource/pubmed/id/12372494

Bioorg. Med. Chem. Lett. 2002 Nov 4 12 21 3027-31

Download in:

View as

General Info

PMID
12372494